Analysis of FOXP3+ regulatory T cell subpopulations in peripheral blood and tissue of patients with systemic lupus erythematosus

被引:21
|
作者
Schmidt, Angelika [1 ,2 ,3 ]
Rieger, Cosima C. [1 ,4 ]
Venigalla, Ram Kumar [5 ,6 ]
Elias, Szabolcs [2 ,3 ]
Max, Regina [5 ]
Lorenz, Hanns-Martin [5 ]
Groene, Hermann-Josef [7 ]
Krammer, Peter H. [1 ]
Kuhn, Annegret [1 ,8 ]
机构
[1] German Canc Res Ctr, Div Immunogenet D030, Tumor Immunol Program, Heidelberg, Germany
[2] Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Unit Computat Med,Ctr Mol Med, Stockholm, Sweden
[3] Sci Life Lab, Stockholm, Sweden
[4] Roche Diabet Care GmbH, Global Med & Sci Affairs, Mannheim, Germany
[5] Heidelberg Univ, Div Rheumatol, Internal Med 5, Heidelberg, Germany
[6] Babraham Inst, Cambridge, England
[7] German Canc Res Ctr, Dept Cellular & Mol Pathol, Heidelberg, Germany
[8] Univ Med Ctr Mainz, Interdisciplinary Ctr Clin Trials IZKS, Mainz, Germany
关键词
Autoimmune diseases; Regulatory T cells; FOXP3; Systemic lupus erythematosus (SLE); AUTOIMMUNE-DISEASES; RHEUMATOID-ARTHRITIS; HUMAN SKIN; EXPRESSION; MIGRATION; NUMBER; SLE; CLASSIFICATION; SUPPRESSION; VIVO;
D O I
10.1007/s12026-017-8904-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulatory T cells (Tregs) are critical mediators of immune tolerance, yet their involvement in the autoimmune disease systemic lupus erythematosus (SLE) is incompletely understood. We analyzed CD4(+) T cell subpopulations with Treg-related phenotypes and their association with disease activity in peripheral blood (PB) and tissues of patients with SLE. In detail, we quantified subpopulations regarding CD25, FOXP3, CD62L, CCR6, CD27, CD45RA, and CD45RO expression in PB from 31 patients with SLE divided into two disease activity groups and 32 healthy controls using flow cytometry. CD4(+) and FOXP3(+) T cells in skin and kidney biopsies of patients with SLE were quantified by immunohistochemistry. CD4(+)CD25(+/++)FOXP3(+) and CD4(+)CD25(+)CD45RA(-)/CD45RO(+) T cell frequencies were significantly higher in PB from patients with active compared to inactive SLE. The fraction of CD4(+)CD25(++)FOXP3(+) Tregs and CD4(+)CD25(+)CD45RA(+)/CD45RO(-) na < ve Tregs was not significantly different between these groups. CD4(+)CD25(++) Tregs from active SLE patients comprised significantly less CD27(+) cells and more CCR6(+) cells compared to patients with inactive SLE. The percentage of CD4(+)FOXP3(+) T cells among inflammatory infiltrates in skin and kidney biopsies of SLE patients was not different from other inflammatory skin/kidney diseases. In conclusion, although CD4(+)FOXP3(+) T cell frequencies in the inflamed tissues of SLE patients were comparable to other inflammatory diseases, distinct T cell subpopulations appeared misbalanced in PB of patients with active SLE. Here, cells phenotypically resembling activated T cells, but not Tregs, were increased compared to patients with inactive SLE. Within Tregs of patients with active SLE, markers related to Treg function and homing were altered.
引用
收藏
页码:551 / 563
页数:13
相关论文
共 50 条
  • [1] Analysis of FOXP3+ regulatory T cell subpopulations in peripheral blood and tissue of patients with systemic lupus erythematosus
    Angelika Schmidt
    Cosima C. Rieger
    Ram Kumar Venigalla
    Szabolcs Éliás
    Regina Max
    Hanns-Martin Lorenz
    Hermann-Josef Gröne
    Peter H. Krammer
    Annegret Kuhn
    Immunologic Research, 2017, 65 : 551 - 563
  • [2] Altered homeostasis of CD4+ FoxP3+ regulatory T-cell subpopulations in systemic lupus erythematosus
    Suen, Jau-Ling
    Li, Hsiao-Ting
    Jong, Yuh-Jyh
    Chiang, Bor-Luen
    Yen, Jeng-Hsien
    IMMUNOLOGY, 2009, 127 (02) : 196 - 205
  • [3] Reprograming of peripheral Foxp3+ regulatory T cell towards Th17-like cell in patients with active systemic lupus erythematosus
    Jiang, Cen
    Wang, Huaizhou
    Xue, Minghui
    Lin, Lin
    Wang, Jianbiao
    Cai, Gang
    Shen, Qian
    CLINICAL IMMUNOLOGY, 2019, 209
  • [4] Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus
    Alexander, Tobias
    Sattler, Arne
    Templin, Lars
    Kohler, Siegfried
    Gross, Christian
    Meisel, Andreas
    Sawitzki, Birgit
    Burmester, Gerd-Ruediger
    Arnold, Renate
    Radbruch, Andreas
    Thiel, Andreas
    Hiepe, Falk
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (09) : 1549 - 1558
  • [5] Skin-specific reduction of Foxp3+ regulatory T cells in patients with lupus erythematosus
    Franz, B.
    Fritzsching, B.
    Kretz, C.
    Riehl, A.
    Klemke, C. D.
    Oberle, N.
    Sykora, J.
    Hartmann, M.
    Enk, A. H.
    Krammer, P. H.
    Suri-Payer, E.
    Kuhn, A.
    EXPERIMENTAL DERMATOLOGY, 2007, 16 (03) : 209 - 210
  • [6] Effects of glucocorticoiids on expression of CD4+ Foxp3+ T cell in patients with systemic lupus erythematosus
    Zhao, Sheng -Nan
    Hou, Ya -Yi
    Sun, Ling-Yun
    PROGRESS ON POST-GENOME TECHNOLOGIES, 2007, : 315 - 317
  • [7] Quantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosus
    Habibagahi, Mojtaba
    Habibagahi, Zahra
    Jaberipour, Mansooreh
    Aghdashi, Amir
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (09) : 1219 - 1225
  • [8] Quantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosus
    Mojtaba Habibagahi
    Zahra Habibagahi
    Mansooreh Jaberipour
    Amir Aghdashi
    Rheumatology International, 2011, 31 : 1219 - 1225
  • [9] INCREASED LEVELS OF CIRCULATING HELIOS+ FOXP3+ NATURAL REGULATORY T CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Alexander, Tobias
    Templin, Lars
    Kohler, Siegfried
    Gross, Christian
    Sattler, Arne
    Meisel, Andreas
    Perka, Carsten
    Burmester, Gerd-Ruediger
    Arnold, Renate
    Radbruch, Andreas
    Thiel, Andreas
    Hiepe, Falk
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 : A50 - A50
  • [10] The Prevalence of FOXP3+ Regulatory T-Cells in Peripheral Blood of Patients with NSCLC
    Liu Li
    Qiu Guo Chao
    Liu Zhong Ping
    Chen Xue
    Zhao Yan Xia
    Ding Qian
    Huang Shi-ang
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2009, 24 (03) : 357 - 367